Health Newsletter and Blog

Health Articles in March, 2006

Angina - Heart Disease In Women More Dangerous Than Previously Thought 

Heart Disease In Women More Dangerous Than Previously Thought 
Medical News Today - Mar 21 4:08 PM
Angina, a common form of heart disease, is more dangerous for women than was previously thought, according to a new study published in the Journal of the American Medical Association (JAMA). The collaborative study, led by UCL (University College London) and funded by the British Heart Foundation, found that angina in women is as common as it is in men, in contrast to heart attacks (myocardial Save to My Web

Britain plan will cut hospital use by some 
UPI - Mar 20 12:44 PM
LONDON, March 20 (UPI) — Patients with some chronic illnesses will be treated at home instead of emergency rooms at hospitals in a move to trim Britain’s National Health Service costs.Save to My Web

Aspirin still the best for reducing the heart attack risk 
News-Medical-Net - Mar 13 6:07 AM
New research has revealed that the addition of the blood-thinning drug Plavix to a daily dose of aspirin does not lower the risk of death, heart attack or stroke in high-risk patients.Save to My Web

(AFX UK Focus) 2006-03-14 19:44 GMT: Highlights of rising and falling U.S. stocks - UPDATE 3 
Interactive Investor - Mar 14 12:08 PM
Advanta Corp. raised its regular quarterly dividends to 21.25 cents from 11.34 cents on Class A common stock. The Spring House, Pa., banking company also raised the dividend on Class B common shares to 25.5 cents from 13.61 cents. The higher dividend rates will commence with the second quarter.Save to My Web

Researchers Identify Gene Variations That May Determine Which Heart Failure Patients Are Likely to Benefit from  
[Press Release] Business Wire via Yahoo! Finance - Mar 13 3:18 PM
ATLANTA—-March 13, 2006–Today, NitroMed, Inc. announced preliminary results from ongoing analyses of data collected during the African American Heart Failure Trial , the clinical trial supporting effectiveness of BiDil , that may determine whether specific variations of genes important in cardiovascular diseases can act as genetic markers for heart failure patients who might best respond to Save to My Web

Comparing The AstraZeneca Investigational Drug AZD6140 To Clopidogrel For Inhibition Of Platelet Aggregation 
Medical News Today - Mar 13 4:12 PM
New Phase IIb data unveiled today reported effects of the AstraZeneca investigational antiplatelet drug AZD6140 on inhibition of platelet aggregation compared to clopidogrel in patients with non-ST elevation acute coronary syndromes (NSTE-ACS). AZD6140 is proposed to work by inhibiting the aggregation of platelets in the blood… click link for more info.Save to My Web

Analysis: New drugs lower blood pressure 
MENAFN - Mar 14 11:41 PM
Analysis: New drugs lower blood pressureSave to My Web

Study: bursts of intense exercise can be deadly 
WABC-TV New York - Mar 21 2:17 PM
We’ve all heard that exercise is good for our health. But for some people, sudden bursts of intense exercise can be deadly, causing the heart to stop.Save to My Web

Analysis: New Drugs Lower Blood Pressure 
RedNova - Mar 14 11:15 PM
By ED SUSMAN Researchers reported Tuesday that a new drug to fight the worldwide epidemic of high blood pressure appears effective in early tests.Save to My Web

Boston Scientific, Corautus suspend angina treatment clinical trials 
The Albany Business Review - Mar 14 10:47 AM
Boston Scientific Corp. and Corautus Genetics Inc. have temporarily suspended clinical trials of a treatment for severe angina, after three patients were found to have excess fluid in the sac that surrounds the heart.Save to My Web

Posted in Angina | No Comments »